dichlororibofuranosylbenzimidazole has been researched along with Prostatic Neoplasms in 2 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
Excerpt | Relevance | Reference |
---|---|---|
"Effective treatments for advanced prostate cancer are much needed." | 1.35 | Apoptosis of metastatic prostate cancer cells by a combination of cyclin-dependent kinase and AKT inhibitors. ( Cheng, JQ; Chu, B; Djeu, J; Mohapatra, S; Pledger, WJ; Zhao, X, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mohapatra, S | 1 |
Chu, B | 1 |
Zhao, X | 1 |
Djeu, J | 1 |
Cheng, JQ | 1 |
Pledger, WJ | 1 |
Lee, DK | 1 |
Duan, HO | 1 |
Chang, C | 1 |
2 other studies available for dichlororibofuranosylbenzimidazole and Prostatic Neoplasms
Article | Year |
---|---|
Apoptosis of metastatic prostate cancer cells by a combination of cyclin-dependent kinase and AKT inhibitors.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Caspase 9; Cell Line, Tumor; Chlorp | 2009 |
Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation.
Topics: Cell Line; Cell Nucleus; Cyclin-Dependent Kinase 9; Cyclin-Dependent Kinases; Dichlororibofuranosylb | 2001 |